BIRC3 and breast cancer: Breast cancer patients with different TNM stages such as stages I, II, III, and IV showed 7.8, 8.09, 7.97, and 12.85 mean fold increased cIAP-2 mRNA expression, respectively, and the difference among them was found to be significant (p=0.0002).